2026-04-17T11:34:28Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1939252025-12-05T14:53:26Zcom_2072_1057col_2072_478917col_2072_478924

Non-HDL-cholesterol and C-reactive protein in children and adolescents with type 1 diabetes Prado, María Mercedes Carrizo, Teresita Abregú, Adela Victoria Meroño, Tomás Colesterol Diabetis Joves Cholesterol Diabetes Youth Background: To what extent high sensitivity C-reactive protein (hsCRP) is associated with known cardiovascular risk factors in children with type 1 diabetes (T1D) has not been fully explored. Methods: Forty-two T1D children (age: 12+/-1 years) without hypertension, retinopathy, hypothyroidism, albuminuria or other endocrine diseases and 20 controls were studied. Out of the 42 T1D patients studied 57% were prepubertal or early pubertal (Tanner I/II), 38% were pubertal (Tanner III/IV) and 5% post-pubertal (Tanner V). Results: Children with T1D showed higher hsCRP than controls [0.51 (0.31-1.71 vs. 0.20 (0.20-0.90) mg/L, p<0.05]. However, hsCRP levels were not different in subgroup analysis [hemoglobin A1c (HbA1c)>7.5% or disease duration>3 years] within the group of children with T1D. Conversely, non-high density lipoprotein (HDL)-cholesterol was different in the subgroup analysis. Moreover non-HDL-cholesterol was correlated with age (r=0.37, p<0.01), disease duration (r=0.36, p<0.01) and fasting glucose (r=0.55, p<0.0001). Conclusions: Non-HDL-cholesterol might be more useful than hsCRP to evaluate future cardiovascular risk in children with T1D. 2023-02-22T10:29:12Z 2023-02-22T10:29:12Z 2017-03-01 2023-02-22T10:29:12Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Reproducció del document publicat a: https://doi.org/10.1515/jpem-2016-0307 Journal of Pediatric Endocrinology and Metabolism, 2017, vol. 30, num. 3, p. 285-288 https://doi.org/10.1515/jpem-2016-0307 (c) De Gruyter, 2017 info:eu-repo/semantics/openAccess De Gruyter Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)